These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 765266)

  • 1. Partial characterization of an immunoenhancing factor from allogeneic human lymphocyte cell lines.
    Rubin AS; Macdonald AB
    Immunology; 1976 Jan; 30(1):69-81. PubMed ID: 765266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro.
    Douglas GN; Rubin AS
    Immunology; 1977 Nov; 33(5):745-55. PubMed ID: 338477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
    J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific heterologous enhancement of immune responses. V. Isolation of a soluble enhancing factor from supernatants of specifically stimulated and allogeneically induced lymphoid cells.
    Rubin AS; MacDonald AB; Coons AH
    J Immunol; 1973 Nov; 111(5):1314-25. PubMed ID: 4583072
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF).
    Zeevi A; Goldman I; Rozenszajn LA
    Immunology; 1978 Mar; 34(3):523-31. PubMed ID: 305893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and biochemical characterization of an inhibitor of DNA synthesis produced by an Epstein-Barr virus-transformed B cell line.
    Beneke JS; Qualtiere LF; Nesheim MC; Pearson GR
    J Immunol; 1980 Jun; 124(6):2950-5. PubMed ID: 6246172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and partial characterization of an antibody enhancing factor from leukaemic owl monkey cell cultures.
    MacDonald AB; Fraser CE; Rubin AS
    Immunology; 1978 Jan; 34(1):137-47. PubMed ID: 342395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific heterologous enhancement of immune responses. VI. Partial purification of a nonspecific enhancing factor from supernates of allogeneically stimulated human lymphocyte cell lines.
    Rubin AS; MacDonald AB; Coons AH
    J Exp Med; 1974 Feb; 139(2):439-44. PubMed ID: 4855755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a factor required for the differentiation of myeloid and lymphoid cells in vitro.
    Watson J; Prichard J
    J Immunol; 1972 May; 108(5):1209-17. PubMed ID: 5063804
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient suppression of the humoral immune response mediated by a factor derived from specifically activated, doubly primed lymphoid cells.
    Kempf KE; Rubin AS
    J Immunol; 1977 Aug; 119(2):517-23. PubMed ID: 886185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
    Couderc J; Bleux C; Birrien JL; Liacopoulos P
    Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic suppression: inhibition of antibody plaque forming cells in vitro by non-sensitized lymphoid cells.
    Friedman H
    Transplant Proc; 1969 Mar; 1(1):574-6. PubMed ID: 4944273
    [No Abstract]   [Full Text] [Related]  

  • 13. The xenogeneic effect. II. Requirement for unactivated murine T cells during restoration of immune responsiveness with xenogeneic reconstitution factor.
    Farrar JJ; Fuller-Bonar J
    J Immunol; 1976 Jul; 117(1):274-82. PubMed ID: 778265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a low molecular weight helper factor(s) with thymocyte proliferative activity.
    Koopman WJ; Farrar JJ; Oppenheim JJ; Fuller-Bonar J; Dougherty S
    J Immunol; 1977 Jul; 119(1):55-60. PubMed ID: 301539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factor.
    Rubin AS; Coons AH
    J Exp Med; 1972 Dec; 136(6):1501-17. PubMed ID: 4118414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulatory effects of accessory cells on the generation of cell-mediated immune reactions.
    Miller CL; Mishell RI
    J Immunol; 1975 Feb; 114(2 Pt 1):692-5. PubMed ID: 1091702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the immune response: production of a soluble suppressor by immune spleen cells in vitro.
    Thomas DW; Roberts WK; Talmage DW
    J Immunol; 1975 May; 114(5):1616-22. PubMed ID: 1091708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythroid cells in immunoregulation: characterization of a novel suppressor factor.
    Seledtsova GV; Seledtsov VI; Samarin DM; Senyukov VV; Ivanova IP; Akimenko ZA; Tsyrlova IG; Wolpe SS; Kozlov VA
    Immunol Lett; 2004 May; 93(2-3):171-8. PubMed ID: 15158614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of suppression by a murine nonspecific suppressor-inducer cell line (M1-A5). III. Partial purification of the suppressor cell-inducing factors.
    Almawi WY; Dolphin PJ; Pope BL
    J Mol Cell Immunol; 1987; 3(3):157-66. PubMed ID: 2978241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.